BiotechTubeBiotechTube
Home/Jiangsu Hengrui Medicine/Sun Piaoyang
SP

Sun Piaoyang

Chairman and CEO

Jiangsu Hengrui Medicine

Therapeutic Areas

OncologyAnesthesiaContrast ImagingPain ManagementHematology

Jiangsu Hengrui Medicine Pipeline

DrugIndicationPhase
Camrelizumab (SHR-1210)Multiple cancer typesApproved
PyrotinibHER2-positive breast cancerApproved
FluzoparibBRCA-positive ovarian cancerApproved
SHR-1316Solid tumorsPhase 1/2
SHR-1701Advanced solid tumorsPhase 1
SHR-1905Hematologic malignanciesPhase 1
SevofluraneGeneral anesthesiaApproved
RopivacaineLocal anesthesiaApproved

Leadership Team at Jiangsu Hengrui Medicine

ZY
Zhou Yunquan
President
LQ
Liu Qing
Chief Financial Officer
ZL
Zhang Lianshan
Executive Vice President
YD
Yu Dechao
Chief Scientific Officer
View full Jiangsu Hengrui Medicine profile